# PCB Bancorp: financial statements, quarterly

PCB · Nasdaq · CIK 1423869 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pcb.md) · [Financials](/companies/pcb/financials.md) · [Filings](/companies/pcb/filings.md) · [Insiders](/companies/pcb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pcb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.7](/filings/0001423869-24-000044.md) | [0.7 d](/filings/0001423869-26-000006.md) | [0.7](/filings/0001423869-25-000038.md) | [0.6](/filings/0001423869-25-000043.md) | [0.8](/filings/0001423869-25-000050.md) | [0.7 d](/filings/0001423869-26-000006.md) | [0.7](/filings/0001423869-26-000018.md) | [0.7](/filings/0001423869-26-000027.md) | [0.7](/filings/0001423869-25-000050.md) | [0.8 d](/filings/0001423869-26-000006.md) | [0.8](/filings/0001423869-26-000018.md) | [0.8](/filings/0001423869-26-000027.md) |
| Interest expense | $m | [16.4](/filings/0001423869-23-000053.md) | [19.0 d](/filings/0001423869-24-000006.md) | [22.6](/filings/0001423869-24-000030.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.0](/filings/0001423869-24-000044.md) | [2.4 d](/filings/0001423869-26-000006.md) | [1.8](/filings/0001423869-25-000038.md) | [2.5](/filings/0001423869-25-000043.md) | [2.9](/filings/0001423869-25-000050.md) | [3.3 d](/filings/0001423869-26-000006.md) | [3.1](/filings/0001423869-26-000018.md) | [3.6](/filings/0001423869-26-000027.md) | [4.5](/filings/0001423869-25-000050.md) | [3.9 d](/filings/0001423869-26-000006.md) | [4.3](/filings/0001423869-26-000018.md) | [4.2](/filings/0001423869-26-000027.md) |
| Net income | $m | [7.0](/filings/0001423869-24-000044.md) | [5.9 d](/filings/0001423869-26-000006.md) | [4.7](/filings/0001423869-25-000038.md) | [6.3](/filings/0001423869-25-000043.md) | [7.8](/filings/0001423869-25-000050.md) | [7.0 d](/filings/0001423869-26-000006.md) | [7.7](/filings/0001423869-26-000018.md) | [9.1](/filings/0001423869-26-000027.md) | [11.4](/filings/0001423869-25-000050.md) | [9.2 d](/filings/0001423869-26-000006.md) | [10.7](/filings/0001423869-26-000018.md) | [10.5](/filings/0001423869-26-000027.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001423869-24-000044.md) | not reported | [0.33](/filings/0001423869-25-000038.md) | [0.43](/filings/0001423869-25-000043.md) | [0.52](/filings/0001423869-25-000050.md) | not reported | [0.53](/filings/0001423869-26-000018.md) | [0.62](/filings/0001423869-26-000027.md) | [0.78](/filings/0001423869-25-000050.md) | not reported | [0.74](/filings/0001423869-26-000018.md) | [0.73](/filings/0001423869-26-000027.md) |
| Basic EPS | $ per share | [0.49](/filings/0001423869-24-000044.md) | not reported | [0.33](/filings/0001423869-25-000038.md) | [0.43](/filings/0001423869-25-000043.md) | [0.52](/filings/0001423869-25-000050.md) | not reported | [0.53](/filings/0001423869-26-000018.md) | [0.63](/filings/0001423869-26-000027.md) | [0.79](/filings/0001423869-25-000050.md) | not reported | [0.74](/filings/0001423869-26-000018.md) | [0.73](/filings/0001423869-26-000027.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [192](/filings/0001423869-23-000053.md) | [242](/filings/0001423869-25-000006.md) | [240](/filings/0001423869-24-000030.md) | [178](/filings/0001423869-24-000038.md) | [193](/filings/0001423869-24-000044.md) | [199](/filings/0001423869-26-000006.md) | [214](/filings/0001423869-25-000038.md) | [264](/filings/0001423869-25-000043.md) | [369](/filings/0001423869-25-000050.md) | [207](/filings/0001423869-26-000027.md) | [267](/filings/0001423869-26-000018.md) | [265](/filings/0001423869-26-000027.md) |
| Total assets | $m | [2,568](/filings/0001423869-23-000053.md) | [2,790](/filings/0001423869-25-000006.md) | [2,854](/filings/0001423869-24-000030.md) | [2,853](/filings/0001423869-24-000038.md) | [2,890](/filings/0001423869-24-000044.md) | [3,064](/filings/0001423869-26-000006.md) | [3,184](/filings/0001423869-25-000038.md) | [3,306](/filings/0001423869-25-000043.md) | [3,364](/filings/0001423869-25-000050.md) | [3,282](/filings/0001423869-26-000027.md) | [3,396](/filings/0001423869-26-000018.md) | [3,470](/filings/0001423869-26-000027.md) |
| Total liabilities | $m | [2,226](/filings/0001423869-23-000053.md) | [2,441](/filings/0001423869-25-000006.md) | [2,504](/filings/0001423869-24-000030.md) | [2,499](/filings/0001423869-24-000038.md) | [2,528](/filings/0001423869-24-000044.md) | [2,700](/filings/0001423869-26-000006.md) | [2,813](/filings/0001423869-25-000038.md) | [2,929](/filings/0001423869-25-000043.md) | [2,979](/filings/0001423869-25-000050.md) | [2,892](/filings/0001423869-26-000027.md) | [2,999](/filings/0001423869-26-000018.md) | [3,070](/filings/0001423869-26-000027.md) |
| Shareholders' equity | $m | [342](/filings/0001423869-24-000044.md) | [349](/filings/0001423869-26-000006.md) | [350](/filings/0001423869-25-000043.md) | [353](/filings/0001423869-25-000050.md) | [362](/filings/0001423869-25-000050.md) | [364](/filings/0001423869-26-000027.md) | [371](/filings/0001423869-26-000027.md) | [377](/filings/0001423869-26-000027.md) | [385](/filings/0001423869-25-000050.md) | [390](/filings/0001423869-26-000027.md) | [397](/filings/0001423869-26-000027.md) | [400](/filings/0001423869-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.8 d](/filings/0001423869-24-000044.md) | [9.9 d](/filings/0001423869-26-000006.md) | [8.2](/filings/0001423869-25-000038.md) | [14.6 d](/filings/0001423869-25-000043.md) | [11.9 d](/filings/0001423869-25-000050.md) | [4.2 d](/filings/0001423869-26-000006.md) | [2.3](/filings/0001423869-26-000018.md) | [4.9 d](/filings/0001423869-26-000027.md) | [16.4 d](/filings/0001423869-25-000050.md) | [2.9 d](/filings/0001423869-26-000006.md) | [20.7](/filings/0001423869-26-000018.md) | [1.4 d](/filings/0001423869-26-000027.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001423869-24-000044.md) | [0.3 d](/filings/0001423869-26-000006.md) | [2.2](/filings/0001423869-25-000038.md) | [1.8 d](/filings/0001423869-25-000043.md) | [0.0 d](/filings/0001423869-25-000050.md) | [0.0 d](/filings/0001423869-26-000006.md) | [0.7](/filings/0001423869-26-000018.md) | [1.1 d](/filings/0001423869-26-000027.md) | [0.2 d](/filings/0001423869-25-000050.md) | [0.1 d](/filings/0001423869-26-000006.md) | [0.0](/filings/0001423869-26-000018.md) | [0.1 d](/filings/0001423869-26-000027.md) |
| Dividends paid | $m | [2.6 d](/filings/0001423869-24-000044.md) | [2.6 d](/filings/0001423869-26-000006.md) | [2.6](/filings/0001423869-25-000038.md) | [2.6 d](/filings/0001423869-25-000043.md) | [2.6 d](/filings/0001423869-25-000050.md) | [2.6 d](/filings/0001423869-26-000006.md) | [2.9](/filings/0001423869-26-000018.md) | [2.9 d](/filings/0001423869-26-000027.md) | [2.9 d](/filings/0001423869-25-000050.md) | [2.9 d](/filings/0001423869-26-000006.md) | [3.1](/filings/0001423869-26-000018.md) | [3.1 d](/filings/0001423869-26-000027.md) |
| Share repurchases | $m | [1.1 d](/filings/0001423869-24-000044.md) | [0.9 d](/filings/0001423869-26-000006.md) | [0.0](/filings/0001423869-25-000038.md) | [0.2 d](/filings/0001423869-25-000043.md) | [0.0 d](/filings/0001423869-25-000050.md) | [0.0 d](/filings/0001423869-26-000006.md) | [1.0](/filings/0001423869-26-000018.md) | [1.8 d](/filings/0001423869-26-000027.md) | [2.2 d](/filings/0001423869-25-000050.md) | [2.1 d](/filings/0001423869-26-000006.md) | [0.2](/filings/0001423869-26-000018.md) | [3.6 d](/filings/0001423869-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.1](/filings/0001423869-23-000053.md) | [14.6](/filings/0001423869-24-000030.md) | [14.4](/filings/0001423869-24-000038.md) | [14.4](/filings/0001423869-24-000044.md) | [14.3](/filings/0001423869-25-000038.md) | [14.3](/filings/0001423869-25-000043.md) | [14.4](/filings/0001423869-25-000050.md) | [14.4](/filings/0001423869-26-000018.md) | [14.3](/filings/0001423869-26-000027.md) | [14.3](/filings/0001423869-25-000050.md) | [14.2](/filings/0001423869-26-000018.md) | [14.2](/filings/0001423869-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,044,602 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001423869-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.